Incyte officer proposes $298K sale of common shares
The notice lists five earlier sales, including 23,218 shares on September 15 and 10,801 shares on August 19, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Incyte Corp. officer Pablo Cagnoni filed a notice of a proposed sale of 2,642 common shares, with an aggregate market value of $297,779.82 and an approximate sale date of October 15, 2026, on Nasdaq. The notice identifies the shares as acquired from the issuer through a stock option exercise for cash on October 15, 2026. It also lists five prior sales dated July 31 through September 15, 2026.
Key Figures
Key Terms
Rule 144 regulatory
aggregate market value financial
Stock Option Exercise financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What prior sales did Pablo Cagnoni report for INCY?
AI-generated analysis. How Rhea-AI works. Not financial advice.